GET HELP NOW

Friday, November 24, 2017

Promising new treatment for rare pregnancy cancer leads to remission in patients

http://ift.tt/eA8V8J Three out of four patients with the cancerous forms of gestational trophoblastic disease (GTD) went into remission after receiving the immunotherapy drug pembrolizumab in a clinical trial, report researchers. The trial is the first to show that pembrolizumab can be used to successfully treat women with GTD.

from http://ift.tt/2jYUq4R
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Children whose mothers use marijuana are more likely to try it at younger age

When mothers use marijuana during the first 12 years of their child's life, their cannabis-using children are more likely to start at an...